UA Finance header Logo
Apple Inc.‪$ 335.30‬1.67‪+0.50%‬Alphabet Inc. (google)‪$ 344.13‬-3.55‪-1.02%‬Microsoft Corp.‪$ 526.47‬-2.83‪-0.53%‬Tesla, Inc.‪$ 375.32‬-5.36‪-1.41%‬Bitcoin‪$ 83,099.99‬-2,449.94‪-2.86%‬ETH/USD‪$ 2,558.58‬-138.91‪-5.15%‬Gold‪$ 4,097.62‬-71.77‪-1.72%‬Silver‪$ 59.55‬-1.88‪-3.06%‬Crude Oil‪$ 89.29‬0.24‪+0.27%‬Natural Gaz‪$ 3.18‬0.06‪+1.84%‬Al Rajhi Company for Cooperative Insurance‪SAR 50.80‬-0.30‪-0.59%‬SpaceX‪$ 168.15‬-3.77‪-2.19%‬
AstraZeneca PLC Logo

AstraZeneca PLC (ZEG)

FSX

Currency in EUR
143.45
+3.25 (+2.32%)

Closed

Oct 7, 2026

Day's Range

138.90
143.45

52 wk Range

134.00
180.45

Profile - ZEG - AstraZeneca PLC

Profile

Mic Code

XFRA

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

96.10K

https://www.astrazeneca.com

AstraZeneca PLC is a global biopharmaceutical company that discovers, develops, manufactures, and commercializes prescription medicines. AstraZeneca PLC focuses on major therapeutic areas including oncology, rare diseases, cardiovascular, renal and metabolism, respiratory and immunology, and vaccines and immune therapies. Its portfolio includes treatments used in cancer care, chronic disease management, respiratory conditions, and specialty medicines for rare and complex disorders. The company serves healthcare providers, hospitals, and patients in markets around the world, with a business model centered on research-driven drug development and broad commercial distribution. Headquartered in Cambridge, United Kingdom, AstraZeneca PLC plays a significant role in the global pharmaceutical market through its branded medicines portfolio and ongoing clinical development programs.

Profile Details

Type

Common Stock

Address

1 Francis Crick Avenue

City

Cambridge

State

MI

Zip

CB2 0AA

Country

United Kingdom

Phone

44 20 3749 5000

Key Executives - ZEG - AstraZeneca PLC

Key executives

NamePositionAgePay
Mr. Pascal Claude Roland Soriot D.V.M., M.B.A.CEO & Executive Director667.15M
Dr. Ruud Dobber Ph.D.Executive Vice-President of BioPharmaceuticals Business Unit--
Dr. Susan Mary Galbraith M.D., Ph.D.Executive Vice President of Oncology R&D59-
Mr. David FredricksonExecutive Vice-President of Oncology Haematology Business Unit50-
Mr. Jeffrey Pott J.D.CHRO, Chief Compliance Officer, General Counsel & Member of External Sustainability Advisory Board--
Mr. Joris SilonHead of Investor Relations--
Ms. Iskra ReicExecutive Vice President of International--
Ms. Pam P. ChengEVP of Global opt. & IT, Chief Sust. Officer and Member of External Sust.Adv. Board55-
Ms. Ruth March FMEDSCI, O.B.E., Ph.D.Senior VP of Precision Medicine - R&D Oncology--
Dr. Aradhana Sarin M.D.CFO & Executive Director513.17M

Cross Listings - ZEG - AstraZeneca PLC

Also listed on

The same company trading on other exchanges.

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.